Security · CUSIP 88339KAA0
THERAVANCE BIOPHARMA INC
NOTE 3.250%11/0 · institutional ownership from 13F filings
13F holders
4
Shares held
4.8M
Value held
$4.7M
New / sold out
0 / 0
Added / reduced
0 / 0
net 0 shares
13F holders by quarter
Net shares bought by existing holders
Top holders · Q2 2020
| Manager | Shares | Value | % of portfolio |
|---|---|---|---|
| CAPSTONE INVESTMENT ADVISORS, LLC | 3,000,000 | $2.9M | 0.02% |
| Bank of New York Mellon Corp | 1,300,000 | $1.3M | 0.00% |
| Mohican Financial Management, LLC | 500,000 | $482.0K | 0.87% |
| PROEQUITIES, INC. | 0 | $0 | 0.00% |
Biggest buyers
Nothing to show.
Biggest sellers
Nothing to show.